Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06310187

Little Cigar Oxidants

Oxidative Stress and Harmful Constituent Levels Associated With Little Cigars

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Determine the effects of little cigars on human exposure to tobacco smoke oxidants. In a balanced randomized cross-over study design in cigarette smokers, subjects will be assigned to 3 exposure groups. These include a high oxidant little cigar exposure condition, a low oxidant little cigar exposure condition, and their usual cigarette. Biological samples will be collected before and after product usage.

Detailed description

Exhaled breath condensate samples will be collected at pre-product usage, post-product usage, 30, and 60 minutes. Samples will be analyzed for levels of oxidant markers including 8-isoprostanes, 8-OHdG acrolein adducts and C-reactive protein. Exhaled breath samples will be collected at pre-product usage and post-product usage. Samples will be analyzed for levels of oxidant markers in Volitive Organic Compound (VOC) profiles. Blood samples will be collected at pre-product usage and post-product usage. Samples will be analyzed nicotine, 8-isoprostane and other oxidative makers of stress. Buccal cell samples will be collected at pre-product usage and post-product usage. Samples will be analyzed for 8-OHdG adducts. Salvia samples will be collected at pre-product usage and post-product usage. Samples will be analyzed for 8-OHdG adducts and metabolomic profiles.

Conditions

Interventions

TypeNameDescription
OTHERHigh Oxidant Little CigarSubjects will be given a high oxidant little cigar to use for outcome measure data collection in the lab before and after product usage.
OTHERLow Oxidant Little CigarSubjects will be given a low oxidant little cigar to use for outcome measure data collection in the lab before and after product usage.
OTHERUsual CigaretteSubjects will use their own cigarette for outcome measure data collection in the lab before and after product usage.

Timeline

Start date
2026-03-23
Primary completion
2029-08-01
Completion
2029-08-01
First posted
2024-03-15
Last updated
2026-04-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06310187. Inclusion in this directory is not an endorsement.